MELBOURNE, AUSTRALIA--(Marketwire - October 28, 2008) - Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT), a biopharmaceutical company focused on the research and development of treatments for neurodegenerative disorders, today announced that the Company is scheduled to present at the Rodman & Renshaw 10th Annual Global Healthcare Conference, on November 10, in New York City.
